肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

系统性AL型淀粉样变性患者真实世界队列中尿ACR与24小时蛋白尿的相关性

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

原文发布日期:2020-12-11

DOI: 10.1038/s41408-020-00391-2

类型: Article

开放获取: 是

英文摘要:

摘要翻译: 

原文链接:

文章:

系统性AL型淀粉样变性患者真实世界队列中尿ACR与24小时蛋白尿的相关性

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

原文发布日期:2020-12-11

DOI: 10.1038/s41408-020-00391-2

类型: Article

开放获取: 是

 

英文摘要:

A 24-h urine protein collection (24hUP), the gold standard for measuring albuminuria in systemic AL amyloidosis, is cumbersome and inaccurate. We retrospectively reviewed 575 patients with systemic AL amyloidosis to assess the correlation between a urine albumin to creatinine ratio (uACR) and the 24hUP. The uACR correlated strongly with 24hUP at diagnosis (Pearson’s r = 0.87, 95% CI 0.83–0.90) and during the disease course (Pearson’s r = 0.88, 95% CI 0.86–0.90). A uACR ≥300 mg/g estimated a 24hUP ≥ 500 mg with a sensitivity of 92% and specificity of 97% (area under the receiver operating curve = 0.938, 95% CI 0.919–0.957). A uACR cutoff of 3600 mg/g best predicted a 24hUP > 5000 g (sensitivity 93%, specificity 94%), and renal stage at diagnosis was strongly concordant using either 24hUP or uACR as the proteinuria measure (k = 0.823, 95% CI 0.728–0.919). In patients with serial urine collections, a > 30% decrease in uACR predicted a > 30% decrease in 24hUP with a sensitivity of 94%. In conclusion, the uACR is a reliable and convenient method for ruling out proteinuria >500 mg per day, prognosticating renal outcomes, and assessing renal response to therapy. Further studies are needed to validate the uACR cutoffs proposed in this study.
 

摘要翻译: 

24小时尿蛋白定量作为评估系统性AL淀粉样变性患者蛋白尿的金标准,操作繁琐且结果欠精确。我们回顾性分析了575例系统性AL淀粉样变性患者,评估尿白蛋白肌酐比值与24小时尿蛋白定量的相关性。结果显示,无论是初诊时还是病程中,uACR与24hUP均呈现强相关性。uACR≥300mg/g可判定24hUP≥500mg/天,其敏感度为92%,特异度为97%。uACR临界值3600mg/g能最佳预测24hUP>5000mg/天,诊断敏感度为93%,特异度为94%。采用uACR或24hUP作为蛋白尿评估指标时,初诊肾脏分期具有高度一致性。在系列尿标本检测中,uACR下降>30%可预测24hUP下降>30%,敏感度达94%。结论表明,uACR是排除每日蛋白尿>500mg、预测肾脏预后及评估治疗反应的可靠便捷方法。本研究提出的uACR临界值尚需进一步验证。

 

原文链接:

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……